At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,067 enrolled
Drug / intervention
Pioglitazonedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Actos Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment"
In Brief
An observational study evaluating Pioglitazone for Type 2 Diabetes Mellitus. Completed, enrolled 1,067 participants.
Detailed Summary
The purpose of this study is to investigate the safety and efficacy of long-term treatment with pioglitazone (Actos Tablets) in the routine clinical setting in combination with an insulin product in patients with type 2 diabetes mellitus who responded inadequately when using an insulin product in addition to diet therapy and exercise therapy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2009
First PostedFeb 2014
Primary CompletionJun 2014
TodayJul 2026
First PostedFeb 21, 2014
Enrollment StartJul 30, 2009
Primary CompletionJun 30, 2014
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 12.4 years ago
Interventions
Pioglitazonedrug
Pioglitazone Tablets